Related Experiment Video
Updated: Mar 24, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Diabetes and new-onset atrial fibrillation in a hypertensive population
Lia Alves-Cabratosa1, Maria García-Gil1,2, Marc Comas-Cufí1
1a Vascular Health Research Group (ISV)-Girona, Jordi Gol Institute for Primary Care Research (IDIAP Jordi Gol) , Catalonia , Spain ;
Insights
Diabetes modestly increases the risk of new-onset atrial fibrillation (AF) in hypertensive patients without prior vascular disease. Obesity was a significant factor among diabetic individuals with AF.
Area of Science:
- Cardiology
- Endocrinology
- Epidemiology
Background:
- The link between diabetes and new-onset atrial fibrillation (AF) is debated, with hypertension potentially mediating the association.
- This study investigates the specific role of diabetes in hypertensive individuals without ischemic vascular disease.
Purpose of the Study:
- To determine the association between diabetes and new-onset AF in hypertensive patients without ischemic vascular disease.
- To explore characteristics of diabetes, including duration, treatment, HbA1c, and BMI, in relation to AF risk.
Main Methods:
- A retrospective cohort study analyzed 262,892 hypertensive individuals aged ≥55 without ischemic heart disease, stroke, or peripheral artery disease.
- Cox proportional hazards regression was used to compare AF incidence between diabetic and non-diabetic subgroups.
- Factors like diabetes duration, pharmacological treatment, hemoglobin A1c, and body mass index were analyzed in diabetic patients.
Main Results:
- New-onset AF incidence was 13.3 per 1000 person-years in diabetic patients versus 10.4 in non-diabetic patients.
- Diabetes showed a modest hazard ratio (HR) of 1.11 for new-onset AF.
- Diabetic patients with obesity had a significantly higher HR of 1.41 for new-onset AF.
Conclusions:
- Diabetes is modestly associated with new-onset AF in hypertensive patients lacking ischemic vascular disease.
- Among diabetic patients, obesity was the only significant factor associated with this arrhythmia.
Aim:
The association of diabetes with new-onset atrial fibrillation (AF) remains controversial. Hypertension may partly explain the risk association ascribed to diabetes. We studied the role and characteristics of diabetes in hypertensive patients with no ischemic vascular disease.
Methods:
Records of 262,892 persons from the Information System for the Development of Research in Primary Care in Catalonia (Spain) were examined from July 2006 to December 2011. Included participants were ≥55-years-old and hypertensive with no ischemic heart disease, stroke, or peripheral artery disease. We used Cox proportional hazards regression to model incidences in the diabetic and non-diabetic subgroups of our population, and among diabetic patients, diabetes duration and pharmacological treatment, hemoglobin A1C, and body mass index.
Results:
New-onset AF incidence in diabetic patients was 13.3 per 1000 person-years (mean follow-up: 4.3 years). In non-diabetic patients, it was 10.4 per 1000 person-years (mean follow-up: 4.1 years). Diabetes hazard ratio (HR) for new-onset AF was 1.11 (95% confidence interval (CI): 1.06-1.16). Diabetic patients also diagnosed with obesity had an HR of 1.41 (95% CI: 1.22-1.64).
Conclusion:
Diabetes was modestly associated with new-onset AF in hypertensive patients with no ischemic vascular disease. Among diabetic patients, only obesity reached significance in its association with this arrhythmia.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

